WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 31-July-2017 (data as of 19-July-2017)
Next overall update Fall-2017
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 6'7601 Infant (under 12 months) mortality rate: 202
GDP / capita (US$): 11'2781 Child (under 5 years) mortality rate: 212

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 74  73  73  72  72  70  71  75 
Births
Surviving infants
Pop. less than 5 years
Pop. less than 15 years 18  18  18  19  19  21  23  27 
Female 15-49 years 19  19  19  19  19  18  18  18 

Number of reported cases

(Click for retrospective incidence data for Dominica)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  13 
Mumps
ChartChart
 
Pertussis
ChartChart
 
Polio*
ChartChart
 
Rubella
ChartChart
 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Dominica)
Vaccine year result method % card seen                                                
BCG          98  99*  98  97  98  99  99  65 
DTP1          99*  99*  99  98  98  98 
DTP3          99  98  97  97  97  99  92  63 
DTP4          93  93  93 
IPV1          99*  36 
HepB_BD          99*  90 
HepB3          99  98  97  97  97 
Hib3          99  98  97  97  97  46 
JapEnc         
MCV1          96  96  94  93  99  99  88 
MCV2          92  94  89  91  94 
MenA         
PCV1         
PCV2         
PCV3         
Pol3          99  98  97  96  97  99  94  53 
Rota1         
RotaC         
RCV1          96  96  94  93  99 
TT2plus          99*  10  20 
PAB          99* 
VAD1         
YFV          99* 
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Dominica)
BCG
ChartChart
  98  98  98  97  98  99  99  65 
DTP1
ChartChart
  99  99  99  98  98  99  97  84 
DTP3
ChartChart
  99  98  97  96  97  99  92  63 
HepB3
ChartChart
  99  98  97  96  97 
HepB_BD
ChartChart
 
Hib3
ChartChart
  99  98  97  96  97 
IPV1
  99  36 
MCV1
ChartChart
  96  96  94  93  99  99  88 
MCV2
ChartChart
  92  94  89  91  94 
PCV3
ChartChart
 
Pol3
ChartChart
  99  98  97  96  97  99  94  53 
RCV1
ChartChart
  96  96  94  93  99  99  88 
RotaC
 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth-1 year; Yes
DT 2, 4, 6 months; Yes Children with history of Seizures
DTwP 18 months; 3 years; Yes
DTwPHibHepB 2, 4, 6 months; Yes
HepB_Adult >=15 years; +4 weeks; +6 months; Yes unimmunized adults
HepB_Pediatric birth; Yes Those whose parents are Hep B + or have no Hep B antigen done in pregnance or no record of immunization coverage
Influenza_Adult >= 65 years; Yes and health care workers, adults with chronic diseases, pregnant women
Influenza_Pediatric 6-35 months; Yes and children with chronic illness
IPV 2, 4 months; Yes
MMR 12, 18 months; Yes
OPV 6, 18 months; 3, 10-12 years; Yes
Td 10-12 years; Yes
YF Yes travelers

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  No  No  No  Yes  No  No 
What years does the MYP cover? number NA  NA      2011-2012     
Nº of districts with microplans that include activities to raise immunization coverage number

System performance

Total Nº districts in country number
Nº districts with DTP3 coverage >=80% number
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number
% of districts with MCV1 coverage >=95% From 0 to 100% 86  86  71  43  71  86  100 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  No  No  No  No 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  No 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 96  98  82  110  92  96  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  Yes  No  No  No  No 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.